Arthneeti
All Q2 FY27 results →
MH

Medplus Health Services Ltd

Q2 FY27Retailing

Medplus Health Services Q2 Results 2026 (FY27) investor presentation: Revenue & Margins

Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.

Price₹608
Market cap₹7.3K Cr
P/E34.7
Updated27 Oct 2026
Read2 min read

Medplus Health Services Ltd Q2 FY27 key numbers

Revenue
Year-on-Year (YoY) growth: 21.3% increase over Q2FY26 (₹16,793 million).

As stated in Medplus Health Services Ltd's Q2 FY27 investor presentation · published 27 Oct 2026. Reported figures, not investment advice.

Based on Medplus Health Services Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

The short version

Q2 FY2027 Revenue: ₹20,371 million - Year-on-Year (YoY) growth: 21.3% increase over Q2FY26 (₹16,793 million) - Quarterly growth (QoQ): 8.4% increase over Q1FY27 (₹18,796 million) - Private label EBITDA for Q2FY27: ₹1,906.0 million (9.4% margin), up 14.6% year-on-year (YoY) from ₹1,663.2 million. - Operating EBITDA margin for Q2FY27: 4.8%, up from 3.5% in Q2FY26. - Profit After Tax (PAT) for Q2FY27: ₹560.7 million (2.8% margin), up 1.0% YoY from ₹555.0 million. - Revenue for Q2FY27 grew 21.3% YoY to ₹20,371.1 million.

From Medplus Health Services Ltd's Q2 FY27 earnings-call transcript · updated 27 Oct 2026.

Revenue & Sales Performance

  • Q2 FY2027 Revenue: ₹20,371 million
  • Year-on-Year (YoY) growth: 21.3% increase over Q2FY26 (₹16,793 million)
  • Quarterly growth (QoQ): 8.4% increase over Q1FY27 (₹18,796 million)
  • Private label revenue: Decreased by 0.6% YoY and 0.7% for half year compared to previous year

2 more points from Medplus Health Services Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Medplus Health Services Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

It provides some related insights: - Free Cash Flow calculation references Capex as a use of cash. - Store expansion: - Net additions of 312 stores in H1 FY2027, with 441 gross additions and 226 net additions beyond Tier-One cities, showing ongoing expansion (Page 7 & 13). - Cluster-based expansion strategy focused on deeper penetration in existing and new clusters (Page 10).

2 more points from Medplus Health Services Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Retailing

Ranked on what management guided this quarter

Guidance-ranked
1V2 Retail Ltd
Rev 1Mar 3
2Rentomojo
Rev 1Mar 3
3
Rev 2Mar 2
4
Rev 2Mar 2
5
Rev 2Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Medplus Health Services Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Medplus Health Services Ltd said on order book & pipeline — free account, 30 seconds.

Medplus Health Services Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹2.0K Cr, net profit ₹56 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Medplus Health Services Ltd's management said in earlier quarters

Others in Retailing this season

  • Womancart Ltd (Q2 FY27)

    Revenue from Operations for the quarter ended 30.09.2026 was ₹2,837.72 lakhs (Page 10). Key results statement takeaways from Womancart Ltd's Q2 FY27 results sta

  • Meesho Ltd (Q2 FY27)

    Year-on-year revenue growth: Approximately 34.4% increase ((41,315.82 . Key results statement takeaways from Meesho Ltd's Q2 FY27 results statement — and how it

  • Info Edge (India) Ltd (Q2 FY27)

    Standalone Revenue from Operations Q2FY27:** ₹842 crore, up 12.8% YoY (from ₹746 crore in Q2FY26) (Page 53, 24) . Key investor presentation takeaways from Info

  • Cartrade Tech Ltd (Q2 FY27)

    Consolidated Revenue Q2 FY27:** ₹213.09 crores, up 10% YoY from ₹193.41 crores in Q2 FY26 (Page 7) . Key investor presentation takeaways from Cartrade Tech Ltd'

Compare:vs Eternalvs Avenue Super.vs Trent Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Medplus Health Services Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Medplus Health Services Ltd Q2 FY27 results?

Q2 FY2027 Revenue: ₹20,371 million - Year-on-Year (YoY) growth: 21.3% increase over Q2FY26 (₹16,793 million) - Quarterly growth (QoQ): 8.4% increase over Q1FY27 (₹18,796 million) - Private label EBITDA for Q2FY27: ₹1,906.0 million (9.4% margin), up 14.6% year-on-year (YoY) from ₹1,663.2 million. - Operating EBITDA margin for Q2FY27: 4.8%, up from 3.5% in Q2FY26. - Profit After Tax (PAT) for Q2FY27: ₹560.7 million (2.8% margin), up 1.0% YoY from ₹555.0 million. - Revenue for Q2FY27 grew 21.3% YoY to ₹20,371.1 million.

What is Medplus Health Services Ltd share price analysis?

Medplus Health Services Ltd currently shows a neutral. The stock trades at a P/E of 34.7 with a market cap of ₹7,304 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Medplus Health Services Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.